HAS3 and Alzheimer disease: Increased expression of miR-10a-5p in keratinocytes of AD patients compared with healthy controls is associated with reduced keratinocyte proliferation and migration through targeting hyaluronan synthase (HAS3), a damage-associated positive regulator of keratinocyte function, thereby potentially impairing skin barrier in AD [119].